How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?-Reference-Cited by-同舟云学术

How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?

Published:2023-01-02 Issue:1 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Han Ru¹^ORCID,Gomez Jorge A.²^ORCID,de Veras Bruna³^ORCID,Pinto Thatiana¹^ORCID,Guzman-Holst Adriana¹^ORCID,Nieto Javier⁴^ORCID,van Oorschot Désirée A. M.¹^ORCID

Affiliation:

1. Value Evidence Outcome Department, GSK, Wavre, Belgium

2. Value Evidence Outcome Department, GSK, Buenos Aires, Argentina

3. Value Evidence Outcome Department, GSK, Rio de Janeiro, Brazil

4. Medical Affairs Department, GSK, Panama City, Panama

Funder

GlaxoSmithKline Biologicals SA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2164144

Reference73 articles.

1. Centers for Disease Control and Prevention (CDC). Shingles (herpes zoster); [accessed 2022 Jun 23]. https://www.cdc.gov/shingles/hcp/clinical-overview.html.

2. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence;Oxman MN.;J Am Osteopath Assoc,2009

3. Meta-Regression of Herpes Zoster Incidence Worldwide

4. Risk Factors for Herpes Zoster: A Systematic Review and Meta-analysis

5. Incidence of Herpes Zoster and Persistent Post-Zoster Pain in Adults With or Without Diabetes in the United States

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient Experience of Herpes Zoster Disease in Argentina: Validation of a Health-Related Quality of Life Conceptual Model;Value in Health Regional Issues;2024-11

2. Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia;Infectious Diseases and Therapy;2024-03-17

3. HSV-1 reactivation results in post-herpetic neuralgia by upregulating Prmt6 and inhibiting cGAS-STING;Brain;2024-02-15

4. COVID-19 and herpes zoster: a call to action;Frontiers in Public Health;2023-08-10